DZIF - Deutsches Zentrum für Infektionsforschung
@dzif.bsky.social
Mehr als 700 Ärzt:innen und Forschende aus 35 Einrichtungen mit dem Ziel der Translation – der effektiven Überführung von Forschungsergebnissen in die Klinik #GemeinsamgegenInfektionen
Impressum: dzif.de/de/impressum – dzif.de/de/social-datenschutz
Impressum: dzif.de/de/impressum – dzif.de/de/social-datenschutz
💉New partnership for next-gen mRNA vaccines: Ethris and DZIF combine proprietary, clinically-validated mRNA technology with translational vaccine research to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
Ethris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines | German Center for Infection Research
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategi
www.dzif.de
February 13, 2026 at 7:30 AM
💉New partnership for next-gen mRNA vaccines: Ethris and DZIF combine proprietary, clinically-validated mRNA technology with translational vaccine research to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Today we celebrate International Day of Women and Girls in Science.
Women have shaped breakthroughs from microbiology to antibiotics, saving millions of lives worldwide.
At INCATE, equity isn’t optional — it’s foundational.
When women and girls succeed in science, society succeeds.
Women have shaped breakthroughs from microbiology to antibiotics, saving millions of lives worldwide.
At INCATE, equity isn’t optional — it’s foundational.
When women and girls succeed in science, society succeeds.
February 11, 2026 at 7:40 AM
Today we celebrate International Day of Women and Girls in Science.
Women have shaped breakthroughs from microbiology to antibiotics, saving millions of lives worldwide.
At INCATE, equity isn’t optional — it’s foundational.
When women and girls succeed in science, society succeeds.
Women have shaped breakthroughs from microbiology to antibiotics, saving millions of lives worldwide.
At INCATE, equity isn’t optional — it’s foundational.
When women and girls succeed in science, society succeeds.
🎉 #INCATE appoints Dr. Holger Zimmermann as its first CEO: an important step in shaping the incubator’s future vision and supporting the development of anti-infectives at an early stage in the fight against antimicrobial resistance.
#AMR @incate.bsky.social
#AMR @incate.bsky.social
INCATE appoints first Chief Executive Officer to shape its future vision | German Center for Infection Research
INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced a defining milestone in its instit
www.dzif.de
February 10, 2026 at 9:42 AM
🎉 #INCATE appoints Dr. Holger Zimmermann as its first CEO: an important step in shaping the incubator’s future vision and supporting the development of anti-infectives at an early stage in the fight against antimicrobial resistance.
#AMR @incate.bsky.social
#AMR @incate.bsky.social
💊 Phyton Biotech has successfully completed the technology transfer for manufacturing Corallopyronin A, a novel anti-infective agent that addresses neglected tropical diseases. This achievement paves the way for first-in-human clinical trials.
@helmholtzhzi.bsky.social @unibonn.bsky.social #NTDs
@helmholtzhzi.bsky.social @unibonn.bsky.social #NTDs
Technology transfer for Corallopyronin A successfully completed with Phyton Biotech | German Center for Infection Research
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of
www.dzif.de
February 9, 2026 at 2:08 PM
💊 Phyton Biotech has successfully completed the technology transfer for manufacturing Corallopyronin A, a novel anti-infective agent that addresses neglected tropical diseases. This achievement paves the way for first-in-human clinical trials.
@helmholtzhzi.bsky.social @unibonn.bsky.social #NTDs
@helmholtzhzi.bsky.social @unibonn.bsky.social #NTDs
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Gezielte #Antibiose statt Breitband auf Verdacht: Ein neues Verfahren von @jlugiessen.bsky.social, @dzif.bsky.social, der Inland-Universität Norwegen, @uio.no und @au.dk gewinnt diagnostische Informationen aus Patientenproben in kürzester Zeit – und zeigt so, welche #Antibiotika wirksam sind.
Harnwegsinfektionen: Weg zu weniger Breitband-Antibiotika
Forschungsteam entwickelt schnelle, präzise und kostengünstige Methode zur Analyse der krankheitsverursachenden Bakterien und deren Antibiotika-Empfindlichkeit
healthcare-in-europe.com
February 6, 2026 at 11:42 AM
Gezielte #Antibiose statt Breitband auf Verdacht: Ein neues Verfahren von @jlugiessen.bsky.social, @dzif.bsky.social, der Inland-Universität Norwegen, @uio.no und @au.dk gewinnt diagnostische Informationen aus Patientenproben in kürzester Zeit – und zeigt so, welche #Antibiotika wirksam sind.
With deep sadness, we bid farewell to Professor Oliver T. Keppler, Chair of Virology at the Max von Pettenkofer Institute at Ludwig Maximilian University in Munich. He passed away on January 27, 2026 following a serious illness.
Mourning the loss of Professor Oliver T. Keppler | German Center for Infection Research
Professor Oliver T.
www.dzif.de
February 6, 2026 at 8:55 AM
With deep sadness, we bid farewell to Professor Oliver T. Keppler, Chair of Virology at the Max von Pettenkofer Institute at Ludwig Maximilian University in Munich. He passed away on January 27, 2026 following a serious illness.
🦟 Researchers at the Bernhard Nocht Institute for Tropical Medicine evaluated new combinations of malaria drugs to overcome rising resistance. The results show that the new drugs are safe, well-tolerated, and as effective as standard therapy.
#Malaria #ClinicalTrials t1p.de/ajdb2
#Malaria #ClinicalTrials t1p.de/ajdb2
Powerful medicines against malaria resistance: New drug combinations prove safe, well tolerated, and effective | German Center for Infection Research
Most
www.dzif.de
February 3, 2026 at 2:12 PM
🦟 Researchers at the Bernhard Nocht Institute for Tropical Medicine evaluated new combinations of malaria drugs to overcome rising resistance. The results show that the new drugs are safe, well-tolerated, and as effective as standard therapy.
#Malaria #ClinicalTrials t1p.de/ajdb2
#Malaria #ClinicalTrials t1p.de/ajdb2
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Infections leave traces – we want to understand them.
NAKO contributes its scientific expertise to the National Decade Against Post-Infectious Diseases initiated by the BMFTR. Dorothee Bär launched the National Decade on 30 January 2026.
📸 ©️BMFTR/Hans-Joachim Rickel
👉 nako.de/en/press-rel...
NAKO contributes its scientific expertise to the National Decade Against Post-Infectious Diseases initiated by the BMFTR. Dorothee Bär launched the National Decade on 30 January 2026.
📸 ©️BMFTR/Hans-Joachim Rickel
👉 nako.de/en/press-rel...
NAKO participates in the National Decade of Post-Infectious Diseases – German National Cohort (NAKO)
The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). W...
nako.de
February 2, 2026 at 11:46 AM
Infections leave traces – we want to understand them.
NAKO contributes its scientific expertise to the National Decade Against Post-Infectious Diseases initiated by the BMFTR. Dorothee Bär launched the National Decade on 30 January 2026.
📸 ©️BMFTR/Hans-Joachim Rickel
👉 nako.de/en/press-rel...
NAKO contributes its scientific expertise to the National Decade Against Post-Infectious Diseases initiated by the BMFTR. Dorothee Bär launched the National Decade on 30 January 2026.
📸 ©️BMFTR/Hans-Joachim Rickel
👉 nako.de/en/press-rel...
🎙️ Der neue #Infektiopod ist da! In der aktuellen Podcastfolge geht es um die spannendsten Paper und Veröffentlichungen aus dem Jahr 2025 mit Neuigkeiten zu Tuberkulose, Impfungen und dem Bakterium Staphylococcus aureus. @infektiopod.bsky.social
🔗 Jetzt reinhören: infektiopod.de/infektiopod-...
🔗 Jetzt reinhören: infektiopod.de/infektiopod-...
February 3, 2026 at 8:37 AM
🎙️ Der neue #Infektiopod ist da! In der aktuellen Podcastfolge geht es um die spannendsten Paper und Veröffentlichungen aus dem Jahr 2025 mit Neuigkeiten zu Tuberkulose, Impfungen und dem Bakterium Staphylococcus aureus. @infektiopod.bsky.social
🔗 Jetzt reinhören: infektiopod.de/infektiopod-...
🔗 Jetzt reinhören: infektiopod.de/infektiopod-...
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
@leibniz-dsmz.bsky.social
Dangerous fungal infections - Leibniz Institute DSMZ provides foundation for their investigation
German Leibniz Institute DSMZ makes WHO-listed fungi available to researchers worldwide: www.dsmz.de/press/press-...
Dangerous fungal infections - Leibniz Institute DSMZ provides foundation for their investigation
German Leibniz Institute DSMZ makes WHO-listed fungi available to researchers worldwide: www.dsmz.de/press/press-...
February 2, 2026 at 10:45 AM
@leibniz-dsmz.bsky.social
Dangerous fungal infections - Leibniz Institute DSMZ provides foundation for their investigation
German Leibniz Institute DSMZ makes WHO-listed fungi available to researchers worldwide: www.dsmz.de/press/press-...
Dangerous fungal infections - Leibniz Institute DSMZ provides foundation for their investigation
German Leibniz Institute DSMZ makes WHO-listed fungi available to researchers worldwide: www.dsmz.de/press/press-...
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Auf der Suche nach Ursachen von #LongCOVID hat ein Team am @ciim-hannover.bsky.social Immunzellen von Patient:innen analysiert. Sie fanden molekulare Veränderungen in #Monozyten, die mit der Schwere von Fatigue, Atemwegssymptomen & Entzündungswerten korrelieren.
www.helmholtz-hzi.de/media-center...
www.helmholtz-hzi.de/media-center...
Wie entsteht Long COVID? Neuer Mosaikstein gefunden
Big-Data-Studie des CiiM findet Zusammenhang von Long COVID mit molekularem Zellzustand von Immunzellen.
www.helmholtz-hzi.de
January 29, 2026 at 9:15 AM
Auf der Suche nach Ursachen von #LongCOVID hat ein Team am @ciim-hannover.bsky.social Immunzellen von Patient:innen analysiert. Sie fanden molekulare Veränderungen in #Monozyten, die mit der Schwere von Fatigue, Atemwegssymptomen & Entzündungswerten korrelieren.
www.helmholtz-hzi.de/media-center...
www.helmholtz-hzi.de/media-center...
🌍Today is #WorldNTDDay: a reminder that millions of people are affected by diseases that are largely invisible on the global health agenda. Together with our African Partner Institutions, DZIF scientists are working to improve and develop diagnostics and therapies for neglected tropical diseases.
World Neglected Tropical Diseases Day on January 30 | German Center for Infection Research
The World
www.dzif.de
January 30, 2026 at 1:04 PM
🌍Today is #WorldNTDDay: a reminder that millions of people are affected by diseases that are largely invisible on the global health agenda. Together with our African Partner Institutions, DZIF scientists are working to improve and develop diagnostics and therapies for neglected tropical diseases.
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Join the HZI as a Junior Research Group Leader at @helmholtz-hiri.bsky.social or @helmholtzhips.bsky.social!
We’re seeking exceptional postdocs for the @helmholtz.de Investigator Groups program. Shape cutting-edge research in infection biology & apply by Feb 15!
jobs.helmholtz-hzi.de/job/Saarbr%C...
We’re seeking exceptional postdocs for the @helmholtz.de Investigator Groups program. Shape cutting-edge research in infection biology & apply by Feb 15!
jobs.helmholtz-hzi.de/job/Saarbr%C...
January 29, 2026 at 1:07 PM
Join the HZI as a Junior Research Group Leader at @helmholtz-hiri.bsky.social or @helmholtzhips.bsky.social!
We’re seeking exceptional postdocs for the @helmholtz.de Investigator Groups program. Shape cutting-edge research in infection biology & apply by Feb 15!
jobs.helmholtz-hzi.de/job/Saarbr%C...
We’re seeking exceptional postdocs for the @helmholtz.de Investigator Groups program. Shape cutting-edge research in infection biology & apply by Feb 15!
jobs.helmholtz-hzi.de/job/Saarbr%C...
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Metagenom-basierte Schnelldiagnostik für #Harnwegsinfektionen könnte #Antibiotikaverbrauch senken: Forschungsteam von #JLUGiessen und @dzif.bsky.social entwickelt präzise und kostengünstige Methode zur Analyse von Bakterien und deren #Antibiotika-Empfindlichkeit www.uni-giessen.de/de/ueber-uns...
January 29, 2026 at 11:27 AM
Metagenom-basierte Schnelldiagnostik für #Harnwegsinfektionen könnte #Antibiotikaverbrauch senken: Forschungsteam von #JLUGiessen und @dzif.bsky.social entwickelt präzise und kostengünstige Methode zur Analyse von Bakterien und deren #Antibiotika-Empfindlichkeit www.uni-giessen.de/de/ueber-uns...
💉Preparedness for future pandemics: A new long-term clinical study shows for the first time that a MERS vaccine candidate induces a stable, functional immune response in humans that persists for at least two years after a booster vaccination.
Preparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response | German Center for Infection Research
A new study has shown for the first time that an experimental
www.dzif.de
January 28, 2026 at 12:28 PM
💉Preparedness for future pandemics: A new long-term clinical study shows for the first time that a MERS vaccine candidate induces a stable, functional immune response in humans that persists for at least two years after a booster vaccination.
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Join CARB-X Executive Director Kevin Outterson J.D., LL.M., ESQ, and CARB-X Senior Alliance Manager Su Chiang, PhD, at the inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)! #IDSky 🧪
🔗 Register here: bit.ly/49KL5Tg
🔗 Register here: bit.ly/49KL5Tg
January 26, 2026 at 2:02 PM
Join CARB-X Executive Director Kevin Outterson J.D., LL.M., ESQ, and CARB-X Senior Alliance Manager Su Chiang, PhD, at the inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)! #IDSky 🧪
🔗 Register here: bit.ly/49KL5Tg
🔗 Register here: bit.ly/49KL5Tg
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
😷 Für die Diagnose der pulmonalen #Tuberkulose ist meist eine Sputumprobe nötig – doch nicht alle Patienten können genug #Sputum produzieren. Ein neuer Ansatz von @dzif.bsky.social / @fzborstel.bsky.social setzt auf Proben aus Atemschutzmasken.
Schutzmasken als Helfer für die Tuberkulose-Diagnostik
Neues Diagnoseverfahren: Erbsubstanz von Tuberkulosebakterien in Atemschutzmasken bei Patienten mit einer Lungentuberkulose nachgewiesen
healthcare-in-europe.com
January 26, 2026 at 11:31 AM
😷 Für die Diagnose der pulmonalen #Tuberkulose ist meist eine Sputumprobe nötig – doch nicht alle Patienten können genug #Sputum produzieren. Ein neuer Ansatz von @dzif.bsky.social / @fzborstel.bsky.social setzt auf Proben aus Atemschutzmasken.
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
#Resistenzen gehen weiter als gedacht: Nicht nur #Bakterien, sondern auch #Pilze & #Viren lernen, Therapien zu umgehen. Von invasiven Mykosen bis #HIV zeigt sich, dass die drohende postantimikrobielle Ära real ist. Mehr bei @pharmazeitung.bsky.social. www.pharmazeutische-zeitung.de/resistenzen-...
Schleichende Gefahr: Resistenzen jenseits von Antibiotika
Die drohende postantimikrobielle Ära betrifft auch Pilze, Viren und Parasiten. Forscher weltweit suchen nach neuen Wegen, um Resistenzmechanismen ausz...
www.pharmazeutische-zeitung.de
January 22, 2026 at 1:57 PM
#Resistenzen gehen weiter als gedacht: Nicht nur #Bakterien, sondern auch #Pilze & #Viren lernen, Therapien zu umgehen. Von invasiven Mykosen bis #HIV zeigt sich, dass die drohende postantimikrobielle Ära real ist. Mehr bei @pharmazeitung.bsky.social. www.pharmazeutische-zeitung.de/resistenzen-...
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Die Impfempfehlungen der STIKO 2026 sind da!
Wesentliche Änderungen und Ergänzung zum Vorjahr betreffen:
🔵 RSV
🔵 Chikungunya
🔵 Influenza
🔵 Mpox
🔵 Hib
🔵 Herpes zoster
🔵 Meningokokken
🔵 Pneumokokken
Die gesamten Empfehlungen im #EpidBull:
➡️ rki.de/stiko-empfehlungen
Wesentliche Änderungen und Ergänzung zum Vorjahr betreffen:
🔵 RSV
🔵 Chikungunya
🔵 Influenza
🔵 Mpox
🔵 Hib
🔵 Herpes zoster
🔵 Meningokokken
🔵 Pneumokokken
Die gesamten Empfehlungen im #EpidBull:
➡️ rki.de/stiko-empfehlungen
January 22, 2026 at 1:18 PM
Die Impfempfehlungen der STIKO 2026 sind da!
Wesentliche Änderungen und Ergänzung zum Vorjahr betreffen:
🔵 RSV
🔵 Chikungunya
🔵 Influenza
🔵 Mpox
🔵 Hib
🔵 Herpes zoster
🔵 Meningokokken
🔵 Pneumokokken
Die gesamten Empfehlungen im #EpidBull:
➡️ rki.de/stiko-empfehlungen
Wesentliche Änderungen und Ergänzung zum Vorjahr betreffen:
🔵 RSV
🔵 Chikungunya
🔵 Influenza
🔵 Mpox
🔵 Hib
🔵 Herpes zoster
🔵 Meningokokken
🔵 Pneumokokken
Die gesamten Empfehlungen im #EpidBull:
➡️ rki.de/stiko-empfehlungen
🔬🦠𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗗𝗭𝗜𝗙/𝗣𝗘𝗚 𝗝𝗼𝗶𝗻𝘁 𝗠𝗲𝗲𝘁𝗶𝗻𝗴!
We are excited to invite you to the joint Annual Meeting of DZIF & PEG: Explore how infection research is evolving in the age of antibiotic resistance, gender medicine, and precision medicine
📅 February 23–24, 2026
📍 Bonn
🔗 Register now: t1p.de/dzif-peg-2026
We are excited to invite you to the joint Annual Meeting of DZIF & PEG: Explore how infection research is evolving in the age of antibiotic resistance, gender medicine, and precision medicine
📅 February 23–24, 2026
📍 Bonn
🔗 Register now: t1p.de/dzif-peg-2026
January 21, 2026 at 11:35 AM
🔬🦠𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗗𝗭𝗜𝗙/𝗣𝗘𝗚 𝗝𝗼𝗶𝗻𝘁 𝗠𝗲𝗲𝘁𝗶𝗻𝗴!
We are excited to invite you to the joint Annual Meeting of DZIF & PEG: Explore how infection research is evolving in the age of antibiotic resistance, gender medicine, and precision medicine
📅 February 23–24, 2026
📍 Bonn
🔗 Register now: t1p.de/dzif-peg-2026
We are excited to invite you to the joint Annual Meeting of DZIF & PEG: Explore how infection research is evolving in the age of antibiotic resistance, gender medicine, and precision medicine
📅 February 23–24, 2026
📍 Bonn
🔗 Register now: t1p.de/dzif-peg-2026
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
📢🔜 New #DZG Seminar Series: Computational Topics in Biomedicine
🎙️Topic: Mapping the Human Body One Cell at a Time with Prof. Sarah Teichmann
🗓️ Thursday, January 22, 2026 | 5:00 PM
📍 Online (Zoom) / login via t1p.de/DZG-seminar
The seminar is open to all interested participants. #ResearchforHealth
🎙️Topic: Mapping the Human Body One Cell at a Time with Prof. Sarah Teichmann
🗓️ Thursday, January 22, 2026 | 5:00 PM
📍 Online (Zoom) / login via t1p.de/DZG-seminar
The seminar is open to all interested participants. #ResearchforHealth
January 21, 2026 at 9:34 AM
📢🔜 New #DZG Seminar Series: Computational Topics in Biomedicine
🎙️Topic: Mapping the Human Body One Cell at a Time with Prof. Sarah Teichmann
🗓️ Thursday, January 22, 2026 | 5:00 PM
📍 Online (Zoom) / login via t1p.de/DZG-seminar
The seminar is open to all interested participants. #ResearchforHealth
🎙️Topic: Mapping the Human Body One Cell at a Time with Prof. Sarah Teichmann
🗓️ Thursday, January 22, 2026 | 5:00 PM
📍 Online (Zoom) / login via t1p.de/DZG-seminar
The seminar is open to all interested participants. #ResearchforHealth
😷Tuberculosis diagnosis without sputum! A new prospective study shows that sampling exhaled air with a face mask can detect tuberculosis bacteria, even in cases that sputum tests missed. This non-invasive method could be a promising addition to existing diagnostic techniques. @fzborstel.bsky.social
Non-invasive diagnosis of tuberculosis using respiratory masks | German Center for Infection Research
Diagnosis of pulmonary
www.dzif.de
January 16, 2026 at 7:38 AM
😷Tuberculosis diagnosis without sputum! A new prospective study shows that sampling exhaled air with a face mask can detect tuberculosis bacteria, even in cases that sputum tests missed. This non-invasive method could be a promising addition to existing diagnostic techniques. @fzborstel.bsky.social
🎉Congratulations to Prof. Rolf Müller on his appointment to the Scientific Advisory Board of the European Partnership on One Health Antimicrobial Resistance! This initiative aims to find new ways to treat and prevent resistant infections and fill existing knowledge gaps on #AMR @eupohamr.bsky.social
International consortium against antimicrobial resistance | German Center for Infection Research
Prof.
www.dzif.de
January 14, 2026 at 10:35 AM
🎉Congratulations to Prof. Rolf Müller on his appointment to the Scientific Advisory Board of the European Partnership on One Health Antimicrobial Resistance! This initiative aims to find new ways to treat and prevent resistant infections and fill existing knowledge gaps on #AMR @eupohamr.bsky.social
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Starting 2026 with great news!
We are thrilled to welcome Basilea Pharmaceutica as a new industry partner. This collaboration not only brings strong antibacterial expertise but also expands our scope to antifungals.
Read here ➡️ www.incate.net/basilea-join...
We are thrilled to welcome Basilea Pharmaceutica as a new industry partner. This collaboration not only brings strong antibacterial expertise but also expands our scope to antifungals.
Read here ➡️ www.incate.net/basilea-join...
Basilea joins INCATE to support antifungal innovation - INCATE
January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in [...]
www.incate.net
January 13, 2026 at 7:21 AM
Starting 2026 with great news!
We are thrilled to welcome Basilea Pharmaceutica as a new industry partner. This collaboration not only brings strong antibacterial expertise but also expands our scope to antifungals.
Read here ➡️ www.incate.net/basilea-join...
We are thrilled to welcome Basilea Pharmaceutica as a new industry partner. This collaboration not only brings strong antibacterial expertise but also expands our scope to antifungals.
Read here ➡️ www.incate.net/basilea-join...
Reposted by DZIF - Deutsches Zentrum für Infektionsforschung
Wie tickt das Immunsystem bei #Tuberkulose, wenn die Infektion andere Organe als die Lunge befällt? Forschende haben nun die immunologischen Eigenschaften der extrapulmonalen Tuberkulose im Blut von betroffenen Patientinnen und Patienten entschlüsselt.
Genanalyse eröffnet neue Wege zur Diagnose schwer erkennbarer Tuberkulose
Wie tickt das Immunsystem bei Tuberkulose, wenn die Infektion andere Organe als die Lunge befällt?Forschende haben die immunologischen Eigenschaften der extrapulmonalen Tuberkulose (EPTB) im Blut von ...
deutschezentren.de
January 12, 2026 at 7:43 AM
Wie tickt das Immunsystem bei #Tuberkulose, wenn die Infektion andere Organe als die Lunge befällt? Forschende haben nun die immunologischen Eigenschaften der extrapulmonalen Tuberkulose im Blut von betroffenen Patientinnen und Patienten entschlüsselt.